云芝菌核多糖通过调节肠道微生物群改善 ob/ob 小鼠的高血糖、高血脂和肝脂肪变性。

An insoluble polysaccharide from the sclerotium of Poria cocos improves hyperglycemia, hyperlipidemia and hepatic steatosis in ob/ob mice via modulation of gut microbiota.

机构信息

School of Life Sciences, University of Science and Technology of China, Hefei 230026, China; State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China.

State Key Laboratory of Mycology, Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China; University of Chinese Academy of Sciences, Beijing, 100049, China.

出版信息

Chin J Nat Med. 2019 Jan;17(1):3-14. doi: 10.1016/S1875-5364(19)30003-2.

Abstract

Metabolic syndrome characterized by obesity, hyperglycemia and liver steatosis is becoming prevalent all over the world. Herein, a water insoluble polysaccharide (WIP) was isolated and identified from the sclerotium of Poria cocos, a widely used Traditional Chinese Medicine. WIP was confirmed to be a (1-3)-β-D-glucan with an average Mw of 4.486 × 10 Da by NMR and SEC-RI-MALLS analyses. Furthermore, oral treatment with WIP from P. cocos significantly improved glucose and lipid metabolism and alleviated hepatic steatosis in ob/ob mice. 16S DNA sequencing analysis of cecum content from WIP-treated mice indicated the increase of butyrate-producing bacteria Lachnospiracea, Clostridium. It was also observed that WIP treatment elevated the level of butyrate in gut, improved the gut mucosal integrity and activated the intestinal PPAR-γ pathway. Fecal transplantation experiments definitely confirmed the causative role of gut microbiota in mediating the benefits of WIP. It is the first report that the water insoluble polysaccharide from the sclerotium of P. cocos modulates gut microbiota to improve hyperglycemia and hyperlipidemia. Thereby, WIP from P. cocos, as a prebiotic, has the potential for the prevention or cure of metabolic diseases and may elucidate new mechanism for the efficacies of this traditional herbal medicine on the regulation of lipid and glucose metabolism.

摘要

代谢综合征的特征为肥胖、高血糖和肝脂肪变性,目前在全球范围内普遍流行。本研究从传统中药茯苓的菌核中分离得到一种不溶于水的多糖(WIP)。通过 NMR 和 SEC-RI-MALLS 分析,确定 WIP 是一种(1-3)-β-D-葡聚糖,平均分子量为 4.486×10 Da。此外,口服来自茯苓的 WIP 可显著改善肥胖型 ob/ob 小鼠的糖脂代谢,减轻肝脂肪变性。WIP 处理小鼠盲肠内容物的 16S DNA 测序分析表明,丁酸盐产生菌lachnospiracea 和 clostridium 的数量增加。还观察到 WIP 处理可提高肠道中丁酸盐的水平,改善肠道黏膜完整性并激活肠道 PPAR-γ 通路。粪便移植实验明确证实了肠道微生物群在介导 WIP 益处方面的因果作用。这是首次报道来自茯苓菌核的不溶性多糖通过调节肠道微生物群来改善高血糖和高血脂。因此,作为一种益生元,来自茯苓的 WIP 具有预防或治疗代谢性疾病的潜力,并可能为这种传统草药调节脂质和葡萄糖代谢的功效阐明新的机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索